Skip to main content

Table 3 Complications, treatment and outcome of IE episodes

From: Profile of infective endocarditis observed from 2003 - 2010 in a single center in Italy

 

No. (%)

 

Characteristic

TOTAL

Native valve

Prosthetic valve

p

(189 cases)

(118 cases)

(71 cases)

Complications

    
 

Embolizations*

83 (44%)

56 (47%)

27 (38%)

0.4

 

Heart failure

49 (26%)

32 (27%)

17 (24%)

0.6

 

Arrhythmias

40 (21%)

28 (24%)

12 (17%)

0.3

 

Intracardiac abscess

15 (9%)

6 (5%)

9 (15%)

0.04

 

Renal failure

12 (6%)

6 (5%)

6 (8%)

0.4

 

Septic shock

8 (4%)

2 (2%)

6 (8%)

0.05

Medical treatment

 

Monotherapy

18 (10%)

13 (11%)

5 (7%)

0.02

 

Dual therapy

115 (62%)

78 (68%)

37 (53%)

 

≥three drug therapy

52 (28%)

24 (21%)

28 (40%)

Surgical treatment

 

Medical and surgical

99 (52%)

65 (55%)

34 (47%)

0.3

 

Multiple valve procedures

24 (24%)

18 (15%)

6 (8%)

0.2

Surgical treatment timing

 

Emergency (≤48 h)

4 (4%)

3 (5%)

1 (3%)

0.4

 

Urgent (>48 h and ≤7 days)

12 (12%)

9 (14%)

3 (9%)

 

Elective (> 7 days)

83 (84%)

53 (81%)

30 (88%)

In-hospital mortality

32 (17%)

16 (14%)

16 (23%)

0.1

 

Pre-operative

20 (63%)

11 (69%)

9 (56%)

0.8

 

Intra-operative

2 (6%)

1 (6%)

1 (6%)

 

Post-operative

10 (31%)

4 (25%)

6 (38%)

  1. *Embolizations: Stroke (35, 19%); Non-Stroke (48, 25%) [Pulmonary (21), Cutaneous (5); Upper/lower extremities (3); Myocardial infarction (1); Splenic (12); Bone (6)].